| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |